Sarah Hamburg
Overview
Explore the profile of Sarah Hamburg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
469
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamburg S, Jimenez Rodriguez A, Htet A, Di Nuovo A
Entropy (Basel)
. 2024 Jul;
26(7).
PMID: 39056944
Taking inspiration from humans can help catalyse embodied AI solutions for important real-world applications. Current human-inspired tools include neuromorphic systems and the developmental approach to learning. However, this developmental neurorobotics...
2.
Murray A, Gough G, Cindric A, Vuckovic F, Koschut D, Borelli V, et al.
EBioMedicine
. 2023 Jul;
94:104692.
PMID: 37451904
Background: People with Down syndrome (DS) show clinical signs of accelerated ageing. Causative mechanisms remain unknown and hypotheses range from the (essentially untreatable) amplified-chromosomal-instability explanation, to potential actions of individual...
3.
Saini F, Masina F, Wells J, Rosch R, Hamburg S, Startin C, et al.
Cereb Cortex
. 2023 Jul;
33(16):9639-9651.
PMID: 37401006
Down syndrome (DS) is associated with an ultra-high risk of developing Alzheimer's disease (AD). Understanding variability in pre-AD cognitive abilities may help understand cognitive decline in this population. The mismatch...
4.
Mgaieth F, Baksh R, Startin C, Hamburg S, Hithersay R, Pape S, et al.
Alzheimers Dement
. 2023 Apr;
19(11):5129-5137.
PMID: 37114906
Introduction: Adults with Down syndrome (DS) are at ultra-high risk of developing Alzheimer's disease (AD), characterized by poor episodic memory and semantic fluency in the preclinical phase in the general...
5.
6.
Hamburg S, Bush D, Strydom A, Startin C
J Neurodev Disord
. 2021 Oct;
13(1):48.
PMID: 34649497
Background: Down syndrome (DS) is the most common genetic cause of intellectual disability (ID) worldwide. Understanding electrophysiological characteristics associated with DS provides potential mechanistic insights into ID, helping inform biomarkers...
7.
Alic I, Goh P, Murray A, Portelius E, Gkanatsiou E, Gough G, et al.
Mol Psychiatry
. 2021 Jul;
26(10):5789.
PMID: 34272490
No abstract available.
8.
Pape S, Baksh R, Startin C, Hamburg S, Hithersay R, Strydom A
J Clin Med
. 2021 Apr;
10(9).
PMID: 33925348
Background: People with Down syndrome are at ultra-high risk of developing Alzheimer's dementia. At present, there are no preventative or curative treatments. Evidence from sporadic Alzheimer's disease literature suggests that...
9.
Hithersay R, Baksh R, Startin C, Wijeratne P, Hamburg S, Carter B, et al.
Alzheimers Dement
. 2020 Nov;
17(4):595-604.
PMID: 33226718
Introduction: People with Down syndrome (DS) typically develop Alzheimer's disease (AD) neuropathology before age 40, but a lack of outcome measures and longitudinal data have impeded their inclusion in randomized...
10.
DSouza H, Mason L, Mok K, Startin C, Hamburg S, Hithersay R, et al.
JAMA Netw Open
. 2020 Sep;
3(9):e2018221.
PMID: 32986108
Importance: Risk of Alzheimer disease (AD) is particularly high for individuals with Down syndrome (DS). The ε4 allele of the apolipoprotein E gene (APOE ε4) is associated with an additional...